The clinical evaluation of antiviral agents. Report of a Working Party of the British Society for Antimicrobial Chemotherapy and the Society of Pharmaceutical Medicine.
- Published in:
- 1997
- Publication type:
- journal article
Works matching IS 03057453 AND DT 1997 AND VI 40 AND IP suppl_1
Results: 16
1
2
Untitled.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. iii
- Publication type:
- Article
3
Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 99, doi. 10.1093/jac/40.suppl_1.99
- By:
- Publication type:
- Article
4
Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 93, doi. 10.1093/jac/40.suppl_1.93
- By:
- Publication type:
- Article
5
Safety profile of grepafloxacin compared with other fluoroquinolones.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 83, doi. 10.1093/jac/40.suppl_1.83
- By:
- Publication type:
- Article
6
Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 73, doi. 10.1093/jac/40.suppl_1.73
- By:
- Publication type:
- Article
7
Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 63, doi. 10.1093/jac/40.suppl_1.63
- By:
- Publication type:
- Article
8
The role of fluoroquinolones in respiratory tract infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 59, doi. 10.1093/jac/40.suppl_1.59
- By:
- Publication type:
- Article
9
Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 45, doi. 10.1093/jac/40.suppl_1.45
- By:
- Publication type:
- Article
10
Pharmacokinetics of grepafloxacin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 35, doi. 10.1093/jac/40.suppl_1.35
- By:
- Publication type:
- Article
11
The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 31, doi. 10.1093/jac/40.suppl_1.31
- By:
- Publication type:
- Article
12
The activity of grepafloxacin against respiratory pathogens in the UK.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 27, doi. 10.1093/jac/40.suppl_1.27
- By:
- Publication type:
- Article
13
Antibacterial activity of grepafloxacin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 19, doi. 10.1093/jac/40.suppl_1.19
- By:
- Publication type:
- Article
14
Pneumococcal resistance in the UK.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 11, doi. 10.1093/jac/40.suppl_1.11
- By:
- Publication type:
- Article
15
The damaging role of bacteria in chronic lung infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 5, doi. 10.1093/jac/40.suppl_1.5
- By:
- Publication type:
- Article
16
Grepafloxacin--focus on respiratory infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 1997, v. 40, n. suppl_1, p. 1, doi. 10.1093/jac/40.suppl_1.1
- By:
- Publication type:
- Article